Sina Pirooz

Sina Pirooz is a declared insider of Genix Pharmaceuticals Corporation, with filings sourced from SEDI. Between 27 August 2018 and 19 March 2026, the trades on record add up to 18 filings.

In open-market terms, that means 3 purchases worth €149k on one side and 10 sales worth €34k on the other. No amount is published for 7 filings, which the totals therefore leave out. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 1 share grant and 2 option exercises. In 2026 alone, the filings show 1 purchase and 6 sales.

On 8 September 2026 came the latest disclosure, an option exercise in Genix Pharmaceuticals Corporation. The clock since the last published purchase (8 September 2026) now reads 61 days. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.